medigraphic.com
ISSN 0188-2198 (Impreso)

2001, Número 1

<< Anterior

Rev Mex Cardiol 2001; 12 (1)


Problemas especiales

Exaire ME, Alcocer BL, González CA, Alexanderson REG, Rodríguez SJ

Idioma: Español
Referencias bibliográficas: 44
Paginas: 55-63
Archivo PDF: 182.82 Kb.


FRAGMENTO

HIPERTENSIÓN ARTERIAL Y CARDIOPATÍA ISQUÉMICA

La enfermedad isquémica coronaria, según el estudio Framingham, aumenta con el grado de hipertensión tanto en hombres como en mujeres; en cambio los sujetos normotensos tienen la mitad de riesgo para desarrollar enfermedad coronaria. MacMahon demuestra un incremento absoluto hasta de un 3.5% cuando las cifras diastólicas son mayores a 90 mmHg.
La hipertensión arterial sistémica asociada a cardiopatía isquémica produce aumento de la frecuencia de arritmias no letales hasta en un 86% y letales en el 13%, con mayor riesgo de muerte súbita, lo que puede estar relacionado con una reducción de la reserva coronaria e hipertrofia ventricular izquierda.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Royle DT. The Framingham Study. The epidemiology of atherosclerotic disease. Massachusetts, USA, A Commonwealth Fund Book. 1980; 91-120.

  2. MacMahon S, Peto R, Cufler J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.

  3. Vogt M, Motz W, Scheler S, Strauer BE. Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension. Am J Cardiol 1990; 65: 45G-50G.

  4. Zehender M, Meinertz T, Hohnloser S, Geibel A, Gerish U, Olschewski M, Just H. Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischemia insystemic arterial hypertension. Circulation 1992; 85: 1808-1815.

  5. Dellsperger KO, Marcus ML. The effects of pressure induced cardiac hypertrophy on the functional capacity of coronary circulation. Am J Hypertens 1988; 1: 200-205.

  6. Massie BM, Tubau JF, Szlachcic J et al. Hypertensive heart disease: The critical role of left ventricular hypertrophy. J Cardiovasc Pharmacol 1989; 13(Suppl 1): S18.

  7. Romao N, Ferreira E, Pessanha EA, Lopes KW, Drumond NC, Reis NB. Hemodynamic profile of patients with normal coronary cineangiography. Arq Bras Cardiol 1989; 53: 15-18.

  8. Maranhao R, Arie S, Vinagre CG, Guimaraes JB, Strunz C, Pileggi F. Lipoprotein plasma levels in normal subject and patients with coronary disease confirmed by coronary cineangiography. Arq Bras Cardiol 1991; 56: 121-125.

  9. Samuelsson O. Experiences from hypertension trials. Impact of other risk factors. Drugs 1988; 36(Suppl 3): 9.

  10. Medical Research Council Working Party: MRC: Trial of treatment of mild hypertension. Principal results. Br Med J 1985: 291-297.

  11. Amery A, Birkenhäger W, Brixko P et al. Mortality and morbidity results from the European Working Party, on high blood pressure in the elderly trial. Lancet 1985; 1: 1349-1354.

  12. Francisco LL, Ferris TF. The use and abuse of diuretics. Arch Intern Med 1982; 142: 28-33.

  13. Frishman WH, Furberg CD, Friedewald WT. Beta-adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med 1984; 310: 830.

  14. Currie WJC, Cooper WD. Safety of angiotensin-converting enzyme inhibitors. Lanct 1985; 1: 580.

  15. Pfeffer MA, Braunwald E, Moyé LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargament trial. N Engl J Med 1992; 327: 669-677.

  16. Theroux P, Taeymans Y, Waters D. Calcium antagonists: Use in the treatment of angina. Drugs 1983; 25: 179.

  17. Hansson L, Zanchetti A, Carruthers Sg, Dahlof B, Elmefeldt D, Menard J et al, for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertensive Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.

  18. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients. N Engl J Med 2000 (in press).

  19. Brown MA, Whitworth JA. Hypertension in human disease. J Hypertens 1992; 10: 701-712.

  20. Guidelines Subcommitte of the WHO/ISH Mild Hypertension Liaison Committee. 1993 guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting. ISH Hypertension 1993: 3-16.

  21. The fith report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (JNC V). Arch Intern Med 1993; 153-154-183.

  22. Anderson S, Rennke HG, Brenner BM. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury. J Hypertens 1986; 4(Suppl 5): S242-S244.

  23. Anderson S, Brenner BM. The role of intraglomerular pressure in the initiation and progression of renal disease. J Hypertens 1986; 4(Suppl 5): S236-S238.

  24. Rodicio JL, Alcázar JM, Ruilope LM. Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria. Kidney Int 1990; 28: 590-594.

  25. Mann JF, Reisch C, Ritz E. Use of angiotensin converting enzyme inhibitors for the preservation of kidney function: a retrospective study. Nephron 1990; 55: S38-S42.

  26. Eliahou HE, Cohen D, Hellberg B. Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man. Am J Nephrol 1988; 8: 285-290.

  27. Doyle AE, Alford F, Cooper ME, De Luise MM, Hammond J, Jerums G et al. A comparison of the effects of blood pressure reduction with perindopril and nifedipine on microalbuminuria in hypertensive and normotensive diabetics. J Hypertens 1989; 7(Suppl 6): S361.

  28. Rodicio JL, Morales JM, Alcázar JM, Ruilope LM. Calcium antagonists and renal protection. J Hypertens 1993; 11 (Suppl 1): S49-S53.

  29. National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group Report on Hypertension and Chronic Renal Failure. Arch Intern Med 1991; 151: 1280-1287.

  30. Assman G, Schulte H. The Prospective Cardiovascular Munster (Prolam) Study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1998; 116: 1713-1724.

  31. Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type II diabetic patients. J Hypertens 1993; 11: 319-325.

  32. Tuck M. Management of hypertension in the patients with diabetes mellitus. Focus on the use of angiotensin-converting enzyme inhibitors. Am J Hypertens 1988; 1(Suppl 2): 384S-388S.

  33. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS. BMJ 1998; 317: 713-720.

  34. Edelson GW, Sowers JR. Treatment of hypertension in selected patients groups: an emphasis on diabetes mellitus and hypertension. Endocrinol 1994; 4: 205-211.

  35. Modan M, Halkin H, Almong S, Lusky A et al. Hiperinsulinemia, a link between hipertensión, obesity and glucose intolerance. J Clin Invest 1985; 75: 809 - 817.

  36. González CHA. Consenso Mexicano de Resistencia a la Insulina y Síndrome Metabólico. Rev Mex Cardiol 1999; 10 (1): 3 -19.

  37. Ferranini E, Natali A. Essential hypertension, metabolic disorders and insulin resistance. Am Heart J 1991; 4: 1274-1282.

  38. Taddei S, Virdis A, Mattei P. Vascular renin anglotensin system and sympathetic nervous system activity in human hypertension. J Cardiovasc Pharmacol 1994; 23 (Supl): s9 - s14.

  39. Wong F, Blendis L, Logan A. Effects of insulin on renal function, sympathetic nervous activity and forearm blood flow in normal human subjects. Clin Invest Med 1997; 20(5): 344-353.

  40. Fyler DC et al. Report of the New England regional infant cardiac program. Pediatrics 1989; 65(Suppl 2): 375.

  41. Parker FB, Streeten DHP, Farrell B, Blackman MS, Sondheimer HM, Anderson GH. Preoperative and postoperative renin levels in coartation of the aorta. Circulation 1982; 66: 513-516.

  42. Bank ER, Aisen AM, Roechini AP et al. Coartation of the aorta in children undergoing angioplasty: Pretreatment and post-treatment MR imagin. Radiology 1987; 162: 235-240.

  43. Lock JE, Bass JL, Amplatz K, Fuhrman BP, Castaneda-Zúñiga W. Balloon dilation angioplasty of aortic coartations in infants and children. Circulation 1983; 68: 109.

  44. Maron BJ. Coartation of the aorta in the adult. In: Robert WC. Congenital heart disease in adults. Philadelphia, USA, FA Davis. 1979; 311.




2020     |     www.medigraphic.com